1-phenyl-2-decanoylamino-3-morpholino-1-propanol and safingol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with safingol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brady, RO; Brown, A; Comly, ME; Cooney, A; Goldin, E; Miller, SP; Pentchev, PG; Roff, CF; Vanier, MT1
Hamanoue, M; Inokuchi, J; Kohsaka, S; Usuki, S1
Billups, C; Cabot, MC; Maurer, BJ; Melton, L; Reynolds, CP1

Reviews

1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and safingol

ArticleYear
Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport.
    Developmental neuroscience, 1991, Volume: 13, Issue:4-5

    Topics: Amines; Androstenes; Animals; Biological Transport; Cells, Cultured; Cholesterol; Cholesterol Esters; Disease Models, Animal; Fibroblasts; Filipin; Humans; Imipramine; Lysosomes; Mice; Morpholines; Niemann-Pick Diseases; Sphingosine; Structure-Activity Relationship

1991

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and safingol

ArticleYear
Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
    Journal of neurochemistry, 1996, Volume: 67, Issue:5

    Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Ceramides; Embryo, Mammalian; Enzyme Inhibitors; Female; Galactose; Gangliosides; Glycosphingolipids; Humans; Kinetics; Morpholines; Neurites; Neurons; Pregnancy; Radioisotope Dilution Technique; Rats; Rats, Wistar; Serine; Sphingomyelins; Sphingosine; Stereoisomerism; Tritium

1996
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Journal of the National Cancer Institute, 2000, Dec-06, Volume: 92, Issue:23

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Ceramides; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor Modulators; Fenretinide; Glucosyltransferases; Humans; Morpholines; Necrosis; Neoplasms; Protein Kinase C; Sphingosine; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000